Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,950
datasets available to search
ShareScore release 0.9.0
Dataset results
10,950 results for “hosting”
Fig. 1 in Mylabrini diversity and host plants in a Saharan oasis ecosystem with an updated checklist of Meloidae from Algeria (Coleoptera)
Fig. 1 – Location of Ouled Djellal Wilaya; sampling sites: 1, Oued El Assel, 2, Oued Djdai 3, Saad.
Dataset for "Decoding host-microbiome interactions through co-expression network analysis within the non-human primate intestine"
<p>Dataset:</p> <p>Data1. Host gene expression profile</p> <p>Data2. Microbiome gene expression profile</p>
Resolving the haplotypes of arbuscular mycorrhizal fungi highlights the role of two nuclear populations in host interactions
<p>This repository contains the annotations, analyses and scripts used to create the figures for the dikaryotic strains of <em>R. irregularis</em> chromosome assemblies.</p>
Fig. 5 in The Australian issid planthopper genus Orinda Kirkaldy, 1907: New subgenera, new species, host plant and identification key (Hemiptera: Fulgoromorpha: Issidae)
Fig. 5. Habitat of Orinda (Montorinda) eungellana sp. nov., Eungella National Park, 17 Mar. 2020.
Niclosamide as a chemical probe for analyzing SARS-CoV-2 modulation of host cell lipid metabolism
<p>SARS-CoV-2 subverts host cell processes to facilitate rapid replication and dissemination, and this leads to pathological inflammation. We used niclosamide (NIC), a poorly soluble anti-helminth drug identified for repurposed treatment of COVID-19, which activates the cells' autophagic and lipophagic processes as a chemical probe to determine if it can modulate the host cell's total lipid profile that would otherwise be either amplified or reduced during SARS-CoV-2 infection. Through parallel lipidomic and transcriptomic analyses we observed massive reorganization of lipid profiles of SARS-CoV-2 infected Vero E6 cells, especially with triglycerides, which were elevated early during virus replication, but decreased thereafter, as well as plasmalogens, which were elevated at later timepoints during virus replication, but were also elevated under normal cell growth. These findings suggested a complex interplay of lipid profile reorganization involving plasmalogen metabolism. We also observed that NIC treatment of both low and high viral loads does not affect virus entry. Instead, NIC treatment reduced the abundance of plasmalogens, diacylglycerides, and ceramides, which we found elevated during virus infection in the absence of NIC, resulting in a significant reduction in the production of infectious virions. Unexpectedly, at higher viral loads, NIC treatment also resulted in elevated triglyceride levels, and induced significant changes in phospholipid metabolism. We posit that future screens of approved drugs should prioritize compounds that effectively counter SARS-CoV-2 subversion of lipid metabolism, thereby reducing virus replication, egress, and the subsequent regulation of key lipid mediators of pathological inflammation.</p>
Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants
ClinicalTrials.gov study NCT00775632. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Can the Reduction of Iron Availability Caused by Tea Consumption Change the Gut Microbiota Composition and Disrupt Host Body-iron Status
ClinicalTrials.gov study NCT05019573. IPD Sharing: YES. Countries: 1. Publications: 0.
Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
ClinicalTrials.gov study NCT05289167. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received
ClinicalTrials.gov study NCT02660684. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease
ClinicalTrials.gov study NCT00228839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease
ClinicalTrials.gov study NCT04198922. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease
ClinicalTrials.gov study NCT04792580. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant
ClinicalTrials.gov study NCT02436460. IPD Sharing: NO. Countries: 1. Publications: 0.
Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).
ClinicalTrials.gov study NCT07314892. IPD Sharing: NO. Countries: 1. Publications: 0.
Chronic Infection With Tropheryma Whipplei: Risk Factors Related to the Host
ClinicalTrials.gov study NCT02868450. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
ClinicalTrials.gov study NCT07300553. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption
ClinicalTrials.gov study NCT06146608. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Host Dendritic Cells in Allograft Patients
ClinicalTrials.gov study NCT00935597. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT
ClinicalTrials.gov study NCT06334367. IPD Sharing: NO. Countries: 1. Publications: 0.
Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease
ClinicalTrials.gov study NCT04328714. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.